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Neonatal respiratory distress syndrome - Chest X-Ray or lung 
ultrasound?  A systematic review. 
 
Abstract 
Background and aim. Neonatal respiratory distress syndrome (NRDS) is a leading 
cause of morbidity in preterm new-born babies (< 37 weeks gestation age [GA]). The 
current diagnostic reference standard includes clinical testing and chest radiography 
(CXR) with associated exposure to ionising radiation. The aim of this review was to 
compare the diagnostic accuracy of lung ultrasound (LUS) against the reference 
standard in symptomatic neonates of ≤ 42 weeks GA.   
Methods.  A systematic search of literature published between 1990 and 2016 
identified 803 potentially relevant studies.  Six studies met the review inclusion 
criteria and were retrieved for analysis. Quality assessment was performed before 
data extraction and meta-analysis. 
Results.  Four prospective cohort studies and two case control studies included 480 
neonates. All studies were of moderate methodological quality although 
heterogeneity was evident across the studies.  The pooled sensitivity and specificity 
of LUS were 97% (95% confidence interval [CI] 94%-99%) and 91% (CI: 86%-95%) 
respectively. False positive diagnoses were made in sixteen cases due to pneumonia 
(n=8), transient tachypnoea (n=3), pneumothorax (n=1) and meconium aspiration 
syndrome (n=1); the diagnoses of the remaining three false positive results were not 
specified. False negatives diagnoses occurred in nine cases, only two were specified 
as air-leak syndromes.  
Conclusions. LUS was highly sensitive for the detection of NRDS although there is 
potential to miss co-morbid air-leak syndromes (ALS). Further research into LUS 
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diagnostic accuracy for neonatal ALS and economic modelling for service integration 
is required before LUS can replace CXR as the imaging component of the reference 
standard.  
Key words. Neonatal respiratory distress syndrome, lung ultrasound, chest X-ray, 
diagnosis. 
 
Introduction 
Neonatal respiratory distress syndrome (NRDS) is a breathing disorder arising at, or 
shortly after birth (<24 hours); it increases in severity during the first 48 hours of life.1 
Although full term new-borns with a gestational age [GA] between 37- 42 weeks can 
be affected, approximately four out of five cases occur in those born prematurely (< 
37 weeks).2,3   Severity and incidence of NRDS are inversely related to GA  with 92% 
of neonates born at 24-25 weeks affected, 88% at 26-27 weeks, 76% at 28-29 weeks 
and 57% at 30-31weeks.4,5  
NRDS is caused by physiological and structural pulmonary immaturity - insufficient 
levels of pulmonary surfactant compromise alveolar integrity, impeding normal gas 
exchange due to deregulation of acinar surface tension.6,7 Resulting atelectasis 
causes decreased lung compliance through an increase of collapsed alveoli in the 
terminal airways.8 NRDS progresses through hypoventilation, hypoxemia and 
respiratory acidosis.6,7,8 It is a leading cause of morbidity in premature new-borns and 
is a common reason for admission to the neonatal intensive care unit (NICU).9,10    
NRDS is diagnosed by a combination of clinical signs and symptoms, laboratory 
analysis and chest radiography (CXR).1,6 Early diagnosis is important so that 
interventional therapy, respiratory support and surfactant replacement, can be 
instigated.7,8 Follow up imaging is required to monitor therapeutic effect and reduce 
broncho-pulmonary dysplasia as a result of unnecessary mechanical ventilation.11 
Page 2 of 38Ultrasound
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Proof
Clinical signs and symptoms 
Clinical presentations of NRDS include non-specific tachypnoea, nasal flaring, 
cyanosis, substernal and intercostal retraction and grunting from expiratory air 
colliding with a partially closed glottis.8  The ‘Clinical Risk Index for Babies’ (CRIB) is 
a risk assessment tool scoring birth weight, gestational age, maximum and minimum 
fraction of inspired oxygen, maximum base excess during the first 12 hours of life  
and presence of congenital malformations.12 In suspected NRDS the CRIB can be 
used to estimate severity of NRDS and trigger administration of assisted ventilation.12  
 
Laboratory tests  
Arterial partial oxygen pressure (PaO2) levels below 50 mmHg with cyanosis in room 
air, or the need for supplementary oxygen to maintain PaO2 > 50 mmHg, is indicative 
of NRDS.6  A blood sample can determine levels of metabolic and respiratory acidosis 
which indicate anaerobic metabolism and atelectasis respectively.13  
 
Swallowed lung fluid is a significant constituent of neonatal gastric aspirate. The 
gastric aspirate shake test (GAST) identifies the presence or a lack of surfactant.14 
GAST is reported to have 100% sensitivity and 92% specificity for NRDS. 15 
 
Chest radiography  
In a study of 59 neonates with clinically suspected NRDS, Vergine et al.16 found CXR 
to have sensitivity and specificity of 91% and 84% respectively when radiologists 
where blinded to clinical test results. Morris17 suggests radiological appearances 
correlate well with clinical disease severity, atelectasis being represented by a bi-
lateral fine granular or “ground glass” appearance such that extent of disease 
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corresponds to level of lung opacity. Reduced lung expansion, dilated bronchioles 
and air bronchograms are also visible depending on disease stage.7   
 
Further to diagnostic use, CXR is used to confirm endotracheal tube (ETT) position;  
premature new-borns with severe NRDS frequently receive continuous positive 
airways pressure (CPAP) in order to improve ventilation and oxygenation as well as 
facilitating intratracheal administration of surfactant.1,6 Confirmation of the ETT 
position minimises lung damage caused by malpositioning1.  
 
Chest radiography involves exposure to ionising radiation. Neonates, due to their 
small size and the close proximity of radiosensitive tissues and organs, are at greater 
risk from latent effects of CXR in comparison to other age groups.18 Although the 
actual risk of adverse latent effects from neonatal radiation exposure has not been 
quantified,19,20 the theoretical risk can be predicted using the linear no-threshold 
(LNT) model with relative risk increasing as absorbed dose increases.20  With 
neonates undergoing multiple CXR examinations during their stay on the NICU, 
efforts have been made to identify an alternative diagnostic test.21,22 
 
Lung ultrasound 
In the past, ultrasound has not been widely used for neonatal chest imaging due to 
the obscuring artefact generated by normal air-filled lung.21 
 
Ultrasound does not involve ionising radiation but is associated with potential risks 
due to mechanical (inertial cavitation) and thermal tissue damage.23 The risk of these 
adverse bio-effects is low in routine clinical practice, but proportional to duration of  
ultrasound examination, dependent on the specific tissues under examination and 
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the output of the ultrasound transducer. Risk is quantified in terms of mechanical and 
thermal indices, MI and TI respectively and displayed during scanning.24 The “as low 
as reasonably practicable” (ALARP) principle, along with acoustic safety guidelines 
are implemented to minimise risk.25  
 
Lung ultrasound (LUS) has recently emerged as a promising diagnostic tool with 
studies reporting accurate results in the diagnosis of NRDS 4,9,11,13,26,27,28 and other 
neonatal pulmonary diseases.22,29 The presence of artefact has been recognised as a 
useful clinical marker to demonstrate normality, its absence being indicative of 
disease (Table 1 and Figure 1a,1b & 1c) 21 .Raised fluid levels in diseased lung and 
the absence of the normal air-filled gap between the pleura and pulmonary 
interstitium provide a propagation medium for ultrasound transmission and 
demonstration of lung tissue.4,9 
 
Ultrasonic verification of ETT position in neonates has also shown potential. Studies 
have reported close correlation between ultrasound and CXR measurements and is 
comparatively much faster 30,31. Due to a lack of high quality supporting evidence 
CXR remains the gold standard.32 
 
Aim 
The aim of this review was to compare the diagnostic accuracy of LUS against  the 
reference standard clinical test and CXR in symptomatic neonates of ≤ 42 weeks 
gestational age.  
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Method 
Search strategy 
Studies were identified during August 2016 using the following databases: OVID 
Embase 1996-2016, OVID Medline (R) 1996-2016, PUBMED 1996-2016, Science 
Direct 1995-2016, Leeds University Library’s Journals/Books@OVID (full-text), 
CINAHL 1990-2016, The Cochrane Library 2005-2016 and Google Scholar. 
 
Initial search terms were identified from a preliminary literature search and accepted 
by unanimous agreement amongst review team members. Medical Subject Headings 
(MeSH) were used to generate additional search terms for ultrasound, neonates, X-
ray and NRDS (Table 2). The Boolean operators (AND) and (OR) were used to 
minimise irrelevant literature and maximise the breadth of the search.33 Truncation 
was used to increase the yield of studies that used alternate endings to the search 
terms.34 
 
Inclusion and exclusion criteria were designed in accordance with the Population, 
Intervention, Comparator, Outcome (PICO) framework to correlate with the research 
question. To increase validity and reproducibility they were defined a priori. Studies 
were included if they were randomized control trials (RCTs), cohort or case-control 
studies, recruited neonates ≤ 42wks GA in a clinical setting with signs and symptoms 
of NRDS within 48 hours of birth, and had NRDS diagnosed using a combination of 
clinical indicators (presentation, vital signs and auscultation), CXR, and/or laboratory 
blood gas analysis. Limited resources restricted inclusion to studies published in 
English.  Although this may introduce language bias33 there is little evidence to 
suggest that systematic bias occurs with such an approach.35 Articles were not 
excluded on the basis of geographical location or publication date to limit bias and 
maximise retrieval of relevant material.33,34 
Page 6 of 38Ultrasound
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Proof
Studies were excluded where it was not possible to extract sufficient data to populate 
2x2 contingency tables, obtain them through the local institutional or British Library, 
where requisite permission from parents and ethical committees had not been 
obtained or where studies collected non-human or cadaveric data. 
 
After removing duplicate results, study titles, abstracts or full-papers were reviewed 
to determine inclusion in the review. Differences of opinion were resolved by 
discussion. The reference lists of included studies were examined to identify further 
relevant studies that had not been retrieved by the database search; forward citation 
tracking was performed in Google Scholar. The rigorous search and selection 
process limited selection bias and reduced the chance of random error.33,34  
 
Quality assessment  
Since the inclusion of studies other than RCTs can increase selection and reporting 
bias,33 quality assessment was performed using the QUADAS-2 (Quality Assessment 
of Diagnostic Accuracy Studies 2) tool.36 Risk of bias and applicability were assessed 
in four key areas relevant to the research question: patient selection, index test, 
reference standard and test flow and timing. Three team members individually scored 
each study awarding one point for each criterion where risk of bias was considered to 
be low.36  
 
Patient selection was considered to have low risk of bias if there was a consecutive 
sample of neonates, they were suspected to have NRDS within 48 hours of birth, and 
subjects had not been excluded inappropriately. Applicability concerns were 
considered low if neonates with congenital heart and chest disease had been 
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excluded, studies were conducted in an appropriate clinical setting and there was no 
evidence of recruitment according to disease severity.  
   
Index test bias criteria required LUS practitioners to be blinded to the results of the 
CXR and applicability concerns related to appropriateness of probe frequency and 
age and capability of equipment. Conversely for the reference standard, clinicians 
would ideally be blinded to the results of the LUS examination (low bias) and the 
clinical test had to be appropriate (applicability).  
    
In terms of flow and timing of the reference and index tests, risk of bias was deemed 
low if all neonates received the same clinical test and a CXR, the interval between 
LUS and CXR was ≤ 5 hours and all recruits where included in 2x2 contingency table 
analysis.  
 
Data extraction and analysis 
Data extraction was carried out independently by MH and CW. The following data 
were extracted: sample size, age range, study design, blinding, method of NRDS 
diagnosis, LUS operator skill level, LUS diagnostic technique, time between CXR and 
LUS, LUS diagnostic criteria and the number of true positives, true negatives, false 
positives and false negatives. 
 
Contingency tables were created to calculate test sensitivity and specificity and the 
DerSimonian and Laird random effects model
37
 was fitted to the data to account for the 
heterogeneity across the studies. Use of a random-effects model is recommended in 
systematic reviews of diagnostic studies due to heterogeneity.33 95% Confidence 
intervals (CIs) were calculated for individual and pooled data. The chi-squared test 
Page 8 of 38Ultrasound
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Proof
(χ2) was applied to assess risk of heterogeneity (p<0.10).31 The Inconsistency (I2) test 
was used to quantify heterogeneity (significance greater than 50%).33 Statistical 
analysis was undertaken using Meta-DiSc ® version 1.4 software.38 
 
Results 
Identification of studies 
The search returned 803 studies of which 10 full texts were assessed for eligibility 
against the inclusion/exclusion criteria. Six of these studies were omitted because 
they had insufficient detail to produce 2x2 contingency tables (n=4)9,24,39,40, reported 
LUS results for lung zones instead of individual neonates (n=1)41 or assessed LUS 
for predicting the need for mechanical ventilation rather than diagnosing NRDS 
(n=1).11 Two further quantitative studies identified through forward and backward 
searching16,42 were included in the analysis (Figure 2). 
 
Study characteristics 
Table 3 details the six studies included for analysis.4,10,13,14,16,42 Four were 
prospective cohort studies4,13,14,16 and two prospective case-control studies.10,42 A 
total of 480 neonates were studied, mean age 31.3 (SD ± 1.1) weeks. Four studies 
(378 neonates) reported gender ratios: 62% of participants were male, 38% female. 
Five studies enrolled participants from single centre NICUs, the other was a two-
centre study.10 Two studies used a transabdominal scanning technique,13,14 three 
adopted a transthoracic approach10,16,42 and one study performed both techniques on 
all enrolled neonates.4 Table 4 summarises the general characteristics of the studies.  
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Quality assessment 
The quality of the studies included in the review was ‘moderate’ with an overall score 
32 out of 42 (Table 5). The reference standard, care settings and level of LUS 
expertise were consistently acceptable across all studies. Double blinding between 
the reference and index tests occurred in three (50%) of the six studies10,13,16 with 
single blinding of the CXR to LUS results occurring in the remaining 50% 4,14,42 . All 
studies conducted CXR first followed by LUS. Four studies stated the interval 
between LUS and CXR as less than 24 hours but failed to provide more precise 
timing13,14,16,42 .Two studies reported LUS and CXR examinations were performed 
within 5 hours of each other 4,10. All studies used a combination of ultrasound findings 
to formulate the diagnostic threshold. The four studies using transthoracic scanning 
diagnosed NRDS on detection of consolidation, pleural line abnormalities and 
bilateral white lung.4,10,16,42 The two studies adopting a transabdominal approach 
defined the presence of retro-diaphragmatic hyper-echogenicity with >3 B-lines as 
indicative of NRDS.13,14 
 
Meta-analysis 
Across the six studies, pooled sensitivity and specificity for the diagnosis of NRDS 
was 0.97 (CI: 0.94-0.99) and 0.91 (CI: 0.86-0.95) respectively (Figures 3a and 3b). 
The  χ2 values were statistically significant (p<0.10) indicating heterogeneity amongst 
the studies due to chance; χ2 22.92 (p=0.0003) and χ2 21.60 (p=0.0006). The I2 
statistic values were 78.2% and 76.9%. Since these values were >50% this was 
considered to be significant heterogeneity based on recommendations from the 
Cochrane handbook (2008)
33
    
Subgroup analysis of the four prospective cohort studies4,13,14,16 showed pooled 
sensitivity of 96% (CI: 92%-98%) and specificity 86% (CI: 79%-92%). For the four 
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studies using transthoracic scanning,4,10,16,42 LUS sensitivity was 99% (CI: 95%-
100%) and specificity 98% (CI: 93%-100%); in comparison the pooled sensitivity of 
the two studies using transabdominal scanning13,14 was 96% (CI: 91-98%) and the 
specificity 83% (CI: 72%-98%). 
 
Discussion 
Diagnostic accuracy of LUS  
Meta-analysis of six studies which compared LUS to CXR and clinical information 
showed high sensitivity (97%) and specificity (91%) for detecting and excluding 
NRDS respectively. Subgroup analysis of the four prospective cohort studies showed 
markedly lower specificity. Although the healthy controls underwent the same index 
and reference tests as the disease group in the two case-control studies, the 
absence of a random or a consecutive sample of participants may have resulted in 
over-estimation of diagnostic accuracy in this subgroup.36 As such we feel the 
subgroup analysis of prospective cohort studies provides the most accurate reflection 
of test accuracy (sensitivity 96%, specificity 86%). 
The transthoracic technique appeared to be superior to the transabdominal approach 
for diagnosing NRDS because subgroup analysis demonstrated it to have marginally 
better sensitivity (99%, 97% respectively) and better specificity (98%, 82% 
respectively). The increased specificity of the transthoracic technique would reduce 
the number of false positive diagnoses and have the clinical benefit of reducing 
unnecessary additional testing or intervention.  
 
Vergine et al.16 measured the diagnostic accuracy of CXR without the addition of 
clinical information and found a sensitivity of 91% and a specificity of 84%. Based on 
these values, LUS appears to be a comparable test. 
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Timing of test performance 
During the acute phase of NRDS the clinical picture can vary significantly over 
time.6,7 Such changes are influenced by naturally increasing disease severity and the 
impact of any treatment provided. It is important when comparing a proposed new 
test with an existing ‘reference’ test that both are carried out within a narrow time 
frame to reduce performance bias.36   Two studies4,10 specified that both tests were 
conducted within 5 hours. The remaining four studies13,14,16,42 completed LUS and 
CXR within 24 hours. This increases the risk of bias due to the possibility that 
changes occurred as a result of advancing disease severity or conversely, due to 
treatment response (Table 5). 34   
 
Limitations of imaging 
The long term biological effects of ultrasound on neonatal lung tissue are unknown.25 
Through prudent clinical use and the avoidance of ionising radiation, LUS is a safer 
alternative to CXR theoretically.21 Despite an established pattern of radiological 
appearances in NRDS findings often overlap with other respiratory pathologies that 
are common among premature neonates.11,21 The static, planar nature of the CXR  
can make differential diagnosis difficult and a degree of inter-observer disagreement 
is inevitable, especially in less advanced disease.21  
 
LUS has its own characteristic signs associated with NRDS, 9,10,11,21 the identification 
of which are aided by real-time visualisation of lung parenchyma and the 
performance of numerous multi-planar sweeps across the lung fields.10, 13 Ultrasound 
is notoriously operator dependant, an inherent source of potential error, 25 although 
utilisation of a standard approach helps to limit operator dependency and can 
improve diagnostic accuracy.21 
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If LUS is to be used as a first line investigation for NRDS it must be carried out soon 
after birth in order to maximise positive health outcomes. This presents economic 
and administrative challenges as LUS would require neonatal clinicians to spend time 
learning a new skill or alternatively, a LUS practitioner would be required to service 
the NICU twenty four hours a week.     
 
Consequences of diagnostic error  
The relatively low (91%) pooled specificity for LUS implied a tendency for over- 
diagnosis of NRDS. Sixteen false positives cases were described across the studies 
due to pneumonia (n=8), transient tachypnoea (n=3), pneumothorax (n-1) and 
meconium aspiration syndrome (n=1); in three cases no alternate diagnosis was 
given.  
 
Pneumonia occurs frequently in new-borns and shares many of the same 
sonographic and radiographic appearances of NRDS. Consolidation with air 
bronchograms, pleural line abnormality, and alveolar interstitial syndrome (presence 
of >3 b-lines) are all associated with the disease.43 Consolidation in severe cases of 
pneumonia is often large with irregular margins; in less severe cases multi-focal 
areas of consolidation can be mistaken for NRDS.44In many cases the diagnosis of 
pneumonia requires bacteriologic culture to identify the presence of infection.7 
 
Transient tachypnoea of the new-born (TTN) occurs in approximately 1% of all new-
borns due to insufficient clearance of foetal lung fluid.16 The resulting respiratory 
distress is accompanied by similar clinico-radiological features to those seen in 
NRDS.  Copetti and Cattarossi45 described ‘the double lung point’ sign in TTN which 
improves the accuracy of LUS for diagnosis (sensitivity 93%, specificity 97%). The 
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‘double lung point’ sign features a normal pleural line with sliding lung, difference in 
echogenicity of lower and upper lung areas, and comet tail artefacts in the inferior 
lung but largely absent in the superior lung.45 All three false positives with TTN were 
from the same study14 which utilised a transabdominal technique. Copetti et al.42 
suggests it is not possible to examine either the superior lung field or the pleural line 
using this approach, which may explain the failures to correctly diagnose the 
condition.    
 
Of the nine false negative cases identified seven were insufficiently reported and the 
eventual diagnosis is unknown. The remaining two were diagnosed by CXR as partial 
pneumothorax. This can be a complication of NRDS along with other associated air-
leak syndromes such as interstitial emphysema,21 pneumomediastinum and 
pneumopericardium.7,10, Air leaks may occur spontaneously, but more commonly 
occur through inadequate mechanical ventilation pressure causing alveolar rupture 
and subsequent escape of air beyond the terminal airways.8 Neonates with NRDS 
have an increased risk of air-leaks due to the delicate nature of the surfactant-
deficient lung and their frequent oxygen therapy requirement.46 Lichtenstein et al47 
defined a pattern of LUS features that can be used to diagnose pneumothorax, 
normal lung sliding and b-lines originating from the visceral pleura are obliterated at 
the site of pneumothorax. The point at which normal findings diminish is ‘the lung 
point’ which demarcates the presence of air in the pleural cavity (pneumothorax) and 
is associated with  79% sensitivity, 100%specificity.47 Both instances of false 
negative pneumothorax were diagnosed by CXR in the study by Lovrenski,4 the 
author maintaining that despite a well-defined pattern, smaller pneumothoraces 
remain diagnostically challenging.  Bober and Swietliński13 support this idea and 
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suggest that an ultrasound beam can propagate through a small pneumothorax into 
the lung field, rendering production of the lung point sign impossible.  
  
Pneumothoraces are also frequently encountered in cases of meconium aspiration 
syndrome which may explain the isolated false positive case identified in this review. 
Air is unable to escape upon exhalation due to airway constriction around aspirated 
meconium which increases the resistance of expiratory airflow. This ‘ball valve’ effect 
creates a volume of trapped gas causing hyperinflation and possible alveolar rupture 
(air-leak).48    
  
The use of LUS for the detection of pneumomediastinum and pneumopericardium is 
yet more contentious with arguments for49,50 and against.10,16 There is little high 
quality evidence to support or deny a role for LUS in this area. This is important, as a 
chief concern with suspected NRDS is the presence of leaking air due to its 
deleterious consequences (tension causing compression of vessels and airways).46 
with this in mind, CXR appears requisite to rule out air-leak syndromes for neonates 
with suspected NRDS. 
 
Summary 
This review has shown that LUS compares well with this current reference standard 
for the diagnosis of NRDS. With appropriate technique and knowledge of 
standardised findings and potential pitfalls, e.g. TTN, pneumothorax, the diagnostic 
accuracy of LUS could be further improved. LUS has superior diagnostic accuracy for 
alveolar consolidation - a major component of the NRDS pattern (90% sensitivity, 
98% specificity). Reduced CXR sensitivity (68% sensitivity 95% specificity) occurs 
when the radiograph is acquired in the supine position – a necessity in neonates.44 
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Less intra-observer variation occurs in LUS identification of small pneumonias and air 
bronchograms - a problematic source of error in CXR reading.51 This may be due to 
real- time visualisation of lung behaviour in synchronisation with the respiratory cycle 
and the ability to access multiple cross sections of the lung fields.13 Reduced lung 
volume, smaller thorax diameter and a thin thoracic wall in neonates may also 
improve image quality.5,13,52      
 
Review limitations. 
A degree of heterogeneity across studies was expected and this was confirmed 
statistically by I2 values greater than 50% across both forest plots (Figures 3a and 
3b). In addition to the differences in study design and scanning technique addressed 
in the subgroup analysis, three other sources of heterogeneity were identified.  
 
LUS operators were not blinded to clinico-radiologic information in 50% of the studies 
(Table 4). As prior knowledge can influence the interpretation of the forthcoming 
examination this could have biased diagnostic accuracy favourably. 
 
With the exception of two studies,4,10  the duration between CXR and subsequent 
LUS was variable. This could have inflated LUS sensitivity due to disease 
progression leading to increased detection of pathology in the second test. 
Conversely, LUS sensitivity for NRDS may have appeared diminished due to the 
effects of surfactant replacement therapy between tests. No study reported 
instigation of treatment during the test interval so the effect of this bias remains 
unknown.   
All studies used signs and symptoms in the clinical diagnosis; only three studies 
included a supplementary blood test.4,10,13 Additional CRIB and GAST tests were 
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used in only two studies.13,14 Differences in the clinical tests used across the studies 
could have introduced bias leading to their varying diagnostic accuracy and 
applicability (Table 4).34,36  
 
The six studies included 480 participants. This sample may not reflect the full 
spectrum of NRDS, or diseases that mimic the appearance of NRDS, which a larger 
sample size might. In cases of non-advanced disease a differential diagnosis with 
LUS becomes harder to define, although this is a problem that is shared with CXR. 
 
Although used as the reference standard the absolute diagnostic accuracy of ‘CXR 
and clinical tests’ has not been verified in neonates.47   
 
Recommendations 
Owing to the frequency of NRDS admissions to NICU’s and the number of CXRs 
performed on neonates, LUS adheres to the ALARP principle by reducing ionising 
radiation burden. The following recommendations are suggested:  
• CXR is required in suspected NRDS to assess for air-leak syndromes.   
• The combination of consolidation, pleural line abnormalities and bilateral 
white lung detected via the transthoracic technique offers the most reliable 
diagnostic criteria (sensitivity 99%, specificity 98%).   
• Future research is required to understand LUS effectiveness as;  
a. An initial screening tool for NRDS and comorbid ALS.  
b. ETT assessment to compare LUS and CXR at four hours of 
postnatal age.  
c. Follow up imaging tool for informing surfactant and ventilatory 
therapy in NRDS patients. 
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d. Comparison of neonatologist vs. ultrasound practitioner vs. 
neonatal nurse practitioner in acquiring and interpreting LUS. 
e. Economic modelling to determine the feasibility of either current 
neonatal staff  learning a new skill, spend time practicing it and 
interpreting the results; number of neonatologists or nurse 
practitioners or ultrasound practitioners to carry out LUS.  
f. Impact on neonatal service delivery 24/7 review. 
 
 
Conclusion   
The diagnostic accuracy of LUS appears to be comparable with the reference 
standard of CXR and clinical tests. However the presence of heterogeneity among 
studies, which have small sample sizes, and no independently validated comparator 
mean the results must be treated cautiously.33 LUS may potentially miss ALS 
(pneumothorax, pneumomediastinum and pneumopericardium), and therefore CXR 
remains necessary for  suspected NRDS. It is a promising technique although 
currently in its infancy with a limited body of experimental studies to support its use. 
High quality RCT studies are required to quantify the diagnostic accuracy of LUS for 
NRDS and comorbid ALS, and to assess LUS effectiveness in follow up imaging. A 
significant role of CXR in NRDS is verification of ETT position for neonates receiving 
invasive ventilation.32 Further study into the effectiveness of ultrasound ETT 
confirmation is required if the absorbed dose of IR is to be reduced. Future research 
should address ways to integrate LUS practice into NICUs in terms of personnel to 
perform the examination and its economic feasibility.   
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Table 1. LUS appearances of the normal and NRDS affected lung21 
LUS Finding Normal Lung Abnormal Lung 
Pleural line 
(lung sliding) 
Smooth echogenic appearance <0.5mm thick. 
Visceral and parietal pleura visualised ‘sliding’ 
with respiration. 
Absence or disruption of the line, >0.5mm 
thickness, no ‘sliding’. 
A-lines (Figure 1a) Equidistant echogenic lines beneath and 
parallel to the pleural line. Reverberation 
artefact caused by large change in acoustic 
impedance at the lung-pleura interface.  
Absent. 
B-lines (Figure 1b) Usually absent, <3 B-lines occasionally 
demonstrated due to watery nature of  the 
neonatal lung, but disappear within 24 hours of 
life. 
 >3 Hyper echoic artifactual lines extending 
vertically from the pleural line into the lung field. 
These lines erase A-lines and move with 
respiration. Delineates increased fluid in the 
interlobular septae between the alveoli.  
B3-lines (Figure 1c) Absent B-lines closely merged (within 3mm) create a 
‘white lung’ appearance through increased 
oedema indicative of alveolar interstitial 
syndrome (AIS). 
Consolidation Absent  Areas of de-arieted lung parenchyma mimicking 
the appearance of the liver (hepatatization), 
and/or presence of air or fluid bronchograms 
delineated by hyper echoic punctate specs and 
branching lines. Indicative of atelectasis. 
Pleural- effusion Absent Anechoic fluid delineated by the pleural line, the 
diaphragm and the lungs visceral surface. 
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Table 2. Search terms 
Neonate (≤42wk) Ultrasound Chest X- Ray Neonatal Respiratory Distress Syndrome 
neonat*, infant*, 
pediatric* 
newborn*, 
preterm, 
premature, 
babies, baby. 
ultraso*, sonog*, 
lung ultrasound,  
  
X-Ray, radiograph*,  conventional 
radiograph*, plain film, radiolog*, 
computed radiography,  digital 
radiography,  radiogram, 
roentgenogram. 
neonatal respiratory distress syndrome, 
infantile respiratory distress syndrome, hyaline 
membrane disease, respiratory distress 
syndrome, 
Pulmonary surfactant, lung disease, respiratory 
disease, surfactant deficiency disorder. 
* Indicates truncation command  
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Table 3. Primary data extracted from retrieved studies for meta-analysis 
  
Study  
 
Year Origin Study type Sample 
size 
Gestational 
age (mean 
± SD 
weeks) 
Male/ 
female, n 
True 
positive 
n 
False 
positive
n 
True 
negative
n 
False 
negative 
n 
Ahuja et al14  2012 India Prospective 88 29+6d ± 11d 50/38 32 6 44 6 
Bober & 
Świetliński13 
2006 Poland Prospective  131 32 ± 4.4 86/45 101 8 22 0 
Copetti et al42 
 
2008 Italy Case -
control  
55 27.2 ± 2.7 unknown 40 0 15 0 
Liu et al10 2014 China Case-
control 
100 34.9 ± 2.7 62/38 50 0 50 0 
Lovrenski4 2012 Serbia prospective  47 30.9 ± 3.16 unknown 43 0 2 2 
Vergine et al16 2014 Italy prospective 59 33 ± 4  36/23 22 2 34 1 
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Study + 
QUDAS-2 
Score 
(0-7) 
Diagnostic 
Method 
LUS 
Operator 
LUS Technique US Equipment LUS Diagnostic 
Criteria 
Time 
Between 
CXR & 
LUS 
Blinding 
Ahuja et al14 
(5) 
Gastric 
aspirate test + 
clinical 
diagnosis + 
CXR   
Radiologist Transabdominal HDI 3500 [Advanced 
Technologies 
Laboratories (ATL) 
Ultrasound, Bothell, WA, 
USA] (5-12 MHz) 
curvilinear probe 
Diffuse 
retrodiaphragmatic 
hyperechogenicity 
completely replacing 
the normal diaphragm  
<20Hrs Not 
blinded 
Bober & 
Świetliński13 
(6) 
CRIB score + 
CXR + blood 
results 
Physician Transabdominal Siemens SI 450, 
unknown origin, equipped 
with a sector 5-MHz  
transducer 
Retrophrenic 
hyperechogenicity  
with B lines diverging 
radially 
<24Hrs Blinded 
Copetti 
et al42 
(4) 
 
Clinical 
diagnosis + 
CXR 
Paediatrician 
+ Cardiologist 
Transthoracic Megas CVX Esaote, 
Medical Systems, 
Florence, Italy (10MHz 
Linear Probe) 
Bi-lateral white lung, 
absence of spared 
areas, thickened and 
irregular pleural line 
<24Hrs Not 
blinded  
Liu et al10 
(6) 
Clinical 
diagnosis + 
CXR + blood 
results 
1 'expert' Transthoracic High resolution line probe 
(11-12 MHz) (GE 
Voluson i or E6, USA) 
 
Consolidation,  
Pleural line 
Abnormalities and 
Bilateral White Lung 
Immediate Blinded 
Lovrenski4 
(5) 
 
Clinical 
Diagnosis + 
CXR + blood 
results 
 
Paediatric 
Radiologist 
Transthoracic +  
Transabdominal 
7.5 MHz linear probe 
(Sonoline Adara, 
Siemens, 
Erlangen, Germany) 
Consolidation; air 
bronchograms  and 
B-Lines  
3.24–4.96 
hours 
Not 
blinded 
Vergine  
et al.16 
(6) 
Clinical 
diagnosis + 
CXR 
Neonatologist Transthoracic Vivid-I Ge Medical 
Systems, Milan, Italy 
using a high res 10-
12MHz linear probe 
Bi-lateral white lung, 
coalescent B-lines & 
thickened and 
irregular pleural line 
<24Hrs Blinded 
Table 4. General study characteristics 
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Table 5. QUADAS-2 Risk of bias and applicability assessment. 
 
Study Risk of Bias Applicability Concerns Score  
 
(0-7) Patient 
Selection 
Index Test 
Reference 
Standard 
Flow and 
Timing 
Patient 
Selection 
Index Test 
Reference 
Standard 
Ahuja et al14  ☺  ☺  ☺ 
☺ 
☺ ☺ 5 
Bober & 
Świetliński13 
☺ ☺ ☺  ☺ ☺ 6 
Copetti et al42   ☺  ☺ ☺ ☺ 4 
Liu et al10  ☺ ☺ ☺ ☺ ☺ ☺ 6 
Lovrenski4 ☺  ☺  ☺ ☺ ☺ 5 
Vergine et al16 ☺ ☺ ☺  ☺ ☺ ☺ 6 
 
☺ = Low  = High
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Figures 1a,1b and 1c. Normal and abnormal transthoracic LUS appearances of NRDS. 
     1a. Normal; A-lines.       1b.  Abnormal; >3 B-lines.               1c.  Abnormal; ‘White-out’. 
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Figure 2. PRISMA flow diagram of search process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records excluded by 
title or abstract 
(n=793) 
 
Records identified 
through database 
searching  
(n=932) 
Records after 
duplicates removed  
(n=803) 
Records screened  
(n=803) 
Full-text articles 
assessed for eligibility  
(n=10) 
Full-text articles 
excluded; (n=6) 
n=4 insufficient data 
to construct 2X2 
tables 
n=1 Incorrect method 
of analysis  
n=1 Incorrect study 
outcome 
 
Studies included in 
quantitative synthesis  
(n=6) 
Articles added from 
citation searching (n=2) 
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Figures 3a and 3b. Forest plots describing the sensitivity (2a) and specificity (2b) of LUS for the diagnosis of NRDS.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3a. 
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3b. 
Page 38 of 38Ultrasound
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
